Effects of Different Doses of Hyperbaric Oxygen on Cisplatin-Induced Nephrotoxicity

REFERENCES

• Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep. 2003; 10: 1663–1682
   PubMed Web of Science ®Google Scholar
• Garnick MB, Mayer RJ, Abelson HT. Acute renal failure associated with cancer treatment. Acute renal failure, BM Brenner, JM Lazarus. Churchill Livingstone, New York 1988; 621–657
   Google Scholar
• Kuhlmann MK, Burkhardt G, Kohler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant. 1997; 12: 2478–2480
   PubMed Web of Science ®Google Scholar
• Conklin KA. Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer. 2000; 37: 1–18
   PubMed Web of Science ®Google Scholar
• Appenroth D, Frob S, Kersten L, et al. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997; 71: 677–683
   PubMed Web of Science ®Google Scholar
• Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol. 2001; 12: 2683–2690
   PubMed Web of Science ®Google Scholar
• Ulubas B, Cimen MY, Apa DD, et al. The protective effects of acetylsalicylic acid on free radical production in cisplatin induced nephrotoxicity: an experimental rat model. Drug Chem Toxicol. 2003; 26: 259–270
   PubMed Web of Science ®Google Scholar
• Ozen S, Akyol O, Iraz M, et al. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. J Appl Toxicol. 2004; 24: 27–35
   PubMed Web of Science ®Google Scholar
• Cetin R, Devrim E, Kilicoglu B, et al. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods. J Appl Toxicol. 2006; 26: 42–46
   PubMed Web of Science ®Google Scholar
• Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000; 109: 665–678
   PubMed Web of Science ®Google Scholar
• Hyperbaric Oxygen 2003: Indications and results. The Hyperbaric Oxygen Committee Report, JJ Feldmeier, MD Kensington. Undersea and Hyperbaric Medical Society, Kensington, Md. 2003
   Google Scholar
• Atasoyu EM, Yildiz S, Bilgi O, et al. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats. Arch Toxicol. 2005; 79: 289–293
   PubMed Web of Science ®Google Scholar
• Yasar M, Yildiz S, Mas R. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiol Res. 2003; 52: 111–116
   PubMed Web of Science ®Google Scholar
• Gulec B, Yasar M, Yildiz S, et al. Effect of hyperbaric oxygen on experimental acute distal colitis. Physiol Res. 2004; 53(5)493–499
   PubMed Web of Science ®Google Scholar
• Ozden TA, Uzun H, Bohloli M. The effects of hyperbaric oxygen treatment on oxidant and antioxidants levels during liver regeneration in rats. Tohoku J Exp Med. 2004; 203: 253–265
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95: 351–358
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988; 34: 497–500
   PubMed Web of Science ®Google Scholar
• Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70: 158–169
   PubMed Web of Science ®Google Scholar
• Ramesh G, Reeves WB. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol. 2003; 285: F610–F618
   PubMed Web of Science ®Google Scholar
• Satoh M, Kashihara N, Fujimoto S. A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Therap. 2003; 305: 1183–1190
   PubMed Web of Science ®Google Scholar
• Jamieson D. Oxygen toxicity and reactive oxygen metabolites in mammals. Free Radic Biol Med. 1989; 7: 87–108
   PubMed Web of Science ®Google Scholar
• Benedetti S, Lamorgese A, Piersantelli M, et al. Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen. Clin Biochem. Apr, 2004; 37(4)312–317
   PubMed Web of Science ®Google Scholar
• Oter S, Korkmaz A, Topal T, et al. Correlation between hyperbaric oxygen exposure pressures and oxidative parameters in rat lung, brain, and erythrocytes. Clin Biochem. Aug, 2005; 38(8)706–711
   PubMed Web of Science ®Google Scholar
• Hink J, Jansen E. Are superoxide and/or hydrogen peroxide responsible for some of the beneficial effects of hyperbaric oxygen therapy?. Med Hypotheses. Dec, 2001; 57(6)764–769
   PubMed Web of Science ®Google Scholar
• Barth E, Sullivan T, Berg E. Animal model for evaluating bone repair with and without adjunctive hyperbaric oxygen therapy (HBO): comparing dose schedules. J Invest Surg. 1990; 3(4)387–392
   PubMedGoogle Scholar
• Conconi MT, Baiguera S, Guidolin D, et al. Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line. J Investig Med. Jul, 2003; 51(4)227–232
   PubMed Web of Science ®Google Scholar
• Kruidering M, Van de Water B, de Heer E, et al. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther. 1997; 280(2)638–649
   PubMed Web of Science ®Google Scholar
• Thom SR, Elbuken ME. Oxygen-dependent antagonism of lipid peroxidation. Free Radic Biol Med. 1991; 10(6)413–426
   PubMed Web of Science ®Google Scholar